|By PR Newswire||
|April 16, 2014 01:00 AM EDT||
TOKYO, April 16, 2014 /PRNewswire/ -- Ajinomoto Pharmaceuticals Co., Ltd. announced on April 16 that the abstract of phase 2a clinical study data of an oral alpha 4 integrin antagonist, development code AJM300, has been accepted for presentation at the Digestive Disease Week 2014 (May 3 - 6 in Chicago, USA). The contents of data will be presented at the beginning of Joint Presidential Plenary Session collaborated by the American Society for Gastrointestinal Endoscopy and the American Gastroenterological Association.
- Study data to be presented (Presentation date / time: USA Eastern time zone)
Abstract No.: 370
AJM300, an Oral alpha 4 Integrin Antagonist, for Active
Ulcerative Colitis: a Multicenter, Randomized, Double-Blind, Placebo-Controlled* Phase 2A Study
Presentation date / time:
May 4, 2014, 1:36-1:46 PM, Oral presentation
*Randomized double-blind, placebo-controlled study
Randomized double-blind, placebo-controlled study is a method of study to objectively evaluate the efficacy of medicine. In the study, neither investigators nor patients know which the patient takes a placebo (a mimic preparation that looks like a study drug but contains no active ingredient) or the study drug.
About Ajinomoto Pharmaceuticals Co., Ltd.
Representative Director,President & CEO: Takashi Nagamachi
Headquarters, Chuo-ku, Tokyo
Corporate Planning Dept
Ajinomoto Pharmaceuticals Co., Ltd.
e-mail: [email protected]
SYS-CON Events announced today that LeaseWeb USA, a cloud Infrastructure-as-a-Service (IaaS) provider, will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. LeaseWeb is one of the world's largest hosting brands. The company helps customers define, develop and deploy IT infrastructure tailored to their exact business needs, by combining various kinds cloud solutions.
Jul. 24, 2016 09:30 AM EDT Reads: 1,050
As companies gain momentum, the need to maintain high quality products can outstrip their development team’s bandwidth for QA. Building out a large QA team (whether in-house or outsourced) can slow down development and significantly increases costs. This eBook takes QA profiles from 5 companies who successfully scaled up production without building a large QA team and includes: What to consider when choosing CI/CD tools How culture and communication can make or break implementation
Jul. 24, 2016 09:00 AM EDT Reads: 1,498
Adding public cloud resources to an existing application can be a daunting process. The tools that you currently use to manage the software and hardware outside the cloud aren’t always the best tools to efficiently grow into the cloud. All of the major configuration management tools have cloud orchestration plugins that can be leveraged, but there are also cloud-native tools that can dramatically improve the efficiency of managing your application lifecycle. In his session at 18th Cloud Expo, ...
Jul. 24, 2016 09:00 AM EDT Reads: 778
Jul. 24, 2016 08:45 AM EDT Reads: 868
Jul. 24, 2016 08:30 AM EDT Reads: 2,049
Jul. 24, 2016 08:30 AM EDT Reads: 1,456
Jul. 24, 2016 08:15 AM EDT Reads: 1,134
Jul. 24, 2016 08:15 AM EDT Reads: 1,809
Jul. 24, 2016 08:15 AM EDT Reads: 1,044
Jul. 24, 2016 08:00 AM EDT Reads: 885
Jul. 24, 2016 08:00 AM EDT Reads: 2,274
Jul. 24, 2016 08:00 AM EDT Reads: 719
Jul. 24, 2016 07:45 AM EDT Reads: 718
Jul. 24, 2016 07:30 AM EDT Reads: 757
Jul. 24, 2016 07:15 AM EDT Reads: 1,939